Latest NBSE reports update at 2023-11-09: 2023-Q3 ∙ 2022-Q4 ∙ 2022-Q3
  1. Home
  2. Stock quotes
  3. NeuBase Therapeutics
  4. Financial Ratios
NeuBase Therapeutics logo
NeuBase Therapeutics NBSE
$ 0.39 -4.5%
mail-toReport an Error

NeuBase Therapeutics Financial Ratios 2011-2024 | NBSE

Annual Financial Ratios NeuBase Therapeutics

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

 - -1.1 -8.8 -1.6 -0.9 -1.1 -3.8 -5.5 -17.4 -23.8 -46.7 -4.9

P/S

 - -121.6 - - - - - - - - - -

EPS

 -1.0 -0.9 -0.9 -3.3 -0.2 -0.5 -0.8 -0.5 -0.4 -0.3 -0.0 -0.1

EV (Enterprise Value)

 -13.7 M -15.5 M 125 M 35 M 12.3 M 19.6 M 89.1 M 58.4 M 151 M 130 M 66.4 M 30.9 M

EBITDA per Share

 -1 -0.96 -0.856 -3.17 -2.82 -10.1 -15.4 -11.5 -7.82 -4.84 -4.49 -1.8

EV/EBITDA

 0.6 -7.3 -1.2 -1.0 -0.6 -3.5 -3.4 -16.8 -28.6 -20.4 -21.3

PEG

 - 0.03 -0.12 -0.05 -0.02 -0.03 0.07 0.17 0.47 0.1 -0.61 0.01

P/B

 - 0.5 4.9 4.3 1.1 1.2 3.9 2.0 5.9 25.6 28.0 -5.3

P/CF

 - -1.4 -13.5 -12.6 -1.2 -1.4 -6.1 -7.7 -17.9 -50.0 -38.0 -25.0

ROE %

 -145.64 -46.99 -55.55 -268.79 -121.43 -104.23 -103.22 -35.77 -34.13 -107.38 -59.96 106.69

ROA %

 -103.31 -39.60 -50.47 -215.13 -113.85 -85.26 -87.51 -32.77 -28.51 -98.41 -41.36 -361.08

ROCE %

 -143.66 -49.13 -54.54 -262.59 -83.28 -103.72 -101.37 -41.11 -34.10 -87.78 -135.45 26.00

Current Ratio

 3.4 6.4 10.4 4.4 5.5 2.6 3.0 7.5 2.5 10.8 2.6 0.1

DSO

 - - - - - - - - - - - -

DIO

 - - - - - - - - - - - -

DPO

 - - - - - - - - - - - -

Operating Cycle

 - - - - - - - - - - - -

Cash Conversion Cycle

 - - - - - - - - - - - -

All numbers in USD currency

Quarterly Financial Ratios NeuBase Therapeutics

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

 -0.66 -2.04 -0.12 -0.13 -4.73 -5.26 -0.3 -0.24 -0.72 -0.29 -0.24 -0.18 -0.69 -0.18 -0.26 -0.26 -0.96 -0.38 -0.26 -0.25 -3.36 -0.19 -0.32 -1.48 -0.45 -0.07 -0.07 -0.21 -0.21 -0.24 -0.21 -0.2 -0.13 -0.11 -0.2 -0.18 -0.12 -0.09 -0.18 -0.1 -0.07 -0.07 -0.1 -0.14 -0.11 -0.03 -0.05 0.01 -0.1 -0.08 -

EBITDA per Share

 -0.98 -2.06 -0.12 -2.66 -4.66 -5.06 -0.3 -0.22 -0.75 -0.29 -0.25 -0.2 -0.64 -0.17 -0.27 -0.21 -0.93 -0.34 -0.21 -0.25 -3.27 -0.31 -0.26 -1.39 -0.43 -0.07 -0.07 -0.2 -0.18 -0.23 -0.2 -0.11 -0.08 -0.1 -0.11 -0.15 -0.14 -0.08 -0.15 -0.1 -0.11 -0.07 -0.1 -0.02 -0.15 -0.04 -0.02 -0.01 -0.02 -0.01 -0.01

ROE %

 -102.88 -115.86 -113.23 -110.90 -103.32 -104.17 -90.53 -87.59 -85.45 -92.23 -91.18 -82.37 -132.22 -147.06 -162.68 -212.53 230.81 277.27 297.31 352.51 -47.81 -120.18 -128.35 -140.53 -146.43 -91.74 -105.51 -112.37 -101.18 -83.80 -60.83 -47.35 -51.63 -53.97 -53.77 -56.49 -83.00 -105.72 -123.47 -144.69 -508.73 -537.21 -530.78 -583.80 -183.33 -42.30 42.30 126.40 78.28 65.62 -7.33

ROA %

 -61.36 -74.93 -80.73 -81.99 -78.46 -83.56 -74.82 -63.09 -62.76 -71.15 -69.68 -72.88 -105.28 -112.76 -117.97 -142.12 -1181.48 -1496.80 -1488.28 -1460.74 -393.47 -100.32 -106.57 -113.03 -118.77 -74.83 -87.02 -95.84 -86.30 -72.19 -53.26 -42.82 -44.36 -45.57 -44.76 -45.86 -74.47 -96.22 -113.12 -133.96 -165.77 -177.65 -167.45 -195.31 -102.53 -324.19 -533.17 -445.28 -264.94 -222.07 24.82

ROCE %

 -50.49 -83.79 -86.13 -112.15 -102.40 -104.97 -92.05 -90.66 -91.51 -93.86 -92.61 -84.32 -121.80 -137.23 -151.72 -189.19 240.14 220.85 237.17 281.99 -114.76 -122.89 -128.20 -140.45 -146.20 -92.40 -105.96 -112.66 -94.90 -75.76 -53.17 -33.68 -43.05 -46.41 -46.24 -52.46 -80.45 -103.19 -120.87 -144.60 -248.83 -298.65 -299.43 -294.61 -129.39 -27.19 -378.20 -334.22 18.15 -377.17 10.40

Current Ratio

 2.0 2.0 3.1 3.5 3.4 4.1 4.6 5.8 6.3 7.7 6.3 13.7 10.9 10.9 10.9 3.5 5.0 5.0 5.0 0.3 0.9 16.0 17.9 6.2 5.5 5.5 5.5 7.7 6.6 6.6 6.6 8.4 11.9 11.9 11.9 4.3 6.1 6.1 6.1 18.3 12.0 12.0 12.0 1.2 3.2 3.2 3.2 0.4 0.2 0.2 0.2

DSO

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DIO

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash Conversion Cycle

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency